Literature DB >> 31568889

Consolidation-to-tumor ratio and tumor disappearance ratio are not independent prognostic factors for the patients with resected lung adenocarcinomas.

Hyungjin Kim1, Jin Mo Goo2, Young Tae Kim3, Chang Min Park4.   

Abstract

OBJECTIVES: Our study aimed to investigate the independent prognostic values of consolidation-to-tumor ratio (CTR) and tumor disappearance ratio (TDR) after adjustment for the conventional prognostic factors and the eighth edition clinical T category for patients with resected lung adenocarcinomas.
MATERIALS AND METHODS: This retrospective study included 691 patients (281 men and 410 women; median age, 63 years) with resected lung adenocarcinomas (clinical T1N0M0). The prognostic implications for disease-free survival (DFS) of CTR and TDR in continuous and categorical forms were analyzed using multivariable-adjusted Cox regression analysis, including multiple clinico-radiological prognostic factors and the clinical T category based on the solid portion measurement. Analysis was performed for the total study population and for two part-solid nodule subgroups (cT1mi/cT1a to cT1c and cT1mi/cT1a to cT1b, respectively).
RESULTS: For the total study population, CTR and TDR were not selected in the multivariable Cox regression models, which indicated that these are not independent prognostic factors. Age (adjusted HR: 1.026; P = 0.022) and clinical T category (adjusted HR for cT1b: 3.475; P = 0.019; adjusted HR for cT1c: 9.938; P < 0.001) were independently associated with DFS. For the part-solid nodule subgroups, multivariable-adjusted HRs for CTR and TDR were not statistically significant (all P > 0.05).
CONCLUSION: CTR and TDR were not independent prognostic factors. Preoperative prognostication based on clinical T category would be sufficient without further stratification according to CTR or TDR.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Consolidation-to-tumor ratio; Disease-free survival; Neoplasm staging; T category; Tumor disappearance ratio

Year:  2019        PMID: 31568889     DOI: 10.1016/j.lungcan.2019.09.014

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  10 in total

1.  The clinical significance of ground glass opacities in lung adenocarcinoma in the era of UICC-TNM classification ver.8.

Authors:  Masayoshi Inoue; Masanori Shimomura
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

2.  Development and validation of a deep learning signature for predicting lymph node metastasis in lung adenocarcinoma: comparison with radiomics signature and clinical-semantic model.

Authors:  Xiaoling Ma; Liming Xia; Jun Chen; Weijia Wan; Wen Zhou
Journal:  Eur Radiol       Date:  2022-09-28       Impact factor: 7.034

3.  The importance of being solid for a ground glass opacity of the lung.

Authors:  Luca Bertolaccini; Lorenzo Spaggiari
Journal:  Ann Transl Med       Date:  2021-07

4.  Prognostic histologic subtyping of dominant tumor in resected synchronous multiple adenocarcinomas of lung.

Authors:  Ping-Chung Tsai; Chia Liu; Yi-Chen Yeh; Chun-Ku Chen; Po-Kuei Hsu; Hui-Shan Chen; Chien-Sheng Huang; Chih-Cheng Hsieh; Han-Shui Hsu; Biing-Shiun Huang
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

5.  Clinical adjustability of radiological tools in patients with surgically resected cT1N0-staged non-small-cell lung cancer from the long-term survival evaluation.

Authors:  Hiroaki Kuroda; Takeo Nakada; Yuko Oya; Yusuke Takahashi; Hirokazu Matsusita; Noriaki Sakakura
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

6.  Implementation of artificial intelligence in the histological assessment of pulmonary subsolid nodules.

Authors:  Jiajun Deng; Mengmeng Zhao; Qiuyuan Li; Yikai Zhang; Minjie Ma; Chuanyi Li; Jun Wang; Yunlang She; Yan Jiang; Yunzeng Zhang; Tingting Wang; Chunyan Wu; Likun Hou; Sheng Zhong; Shengxi Jin; Dahong Qian; Dong Xie; Yuming Zhu; Yasmeen K Tandon; Annemiek Snoeckx; Feng Jin; Bentong Yu; Guofang Zhao; Chang Chen
Journal:  Transl Lung Cancer Res       Date:  2021-12

7.  A radiomics nomogram for invasiveness prediction in lung adenocarcinoma manifesting as part-solid nodules with solid components smaller than 6 mm.

Authors:  Teng Zhang; Chengxiu Zhang; Yan Zhong; Yingli Sun; Haijie Wang; Hai Li; Guang Yang; Quan Zhu; Mei Yuan
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

8.  Efficacy of a combined tool for stage I non-small cell lung cancer against lymph node metastasis.

Authors:  Takeo Nakada; Mitsuo Yabe; Takashi Ohtsuka
Journal:  Oncol Lett       Date:  2022-08-09       Impact factor: 3.111

9.  A predictive nomogram for lymph node metastasis in part-solid invasive lung adenocarcinoma: A complement to the IASLC novel grading system.

Authors:  Zhaoming Gao; Xiaofei Wang; Tao Zuo; Mengzhe Zhang; Zhenfa Zhang
Journal:  Front Oncol       Date:  2022-08-15       Impact factor: 5.738

10.  Verification of the eighth edition of the UICC-TNM classification on surgically resected lung adenocarcinoma: Comparison with previous classification in a local center.

Authors:  Hiroshi Minato; Kazuyoshi Katayanagi; Hiroshi Kurumaya; Nobuhiro Tanaka; Hideki Fujimori; Yoshio Tsunezuka; Takeshi Kobayashi
Journal:  Cancer Rep (Hoboken)       Date:  2021-06-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.